COMPASS Pathways Shares Are Trading Higher After Morgan Stanley Initiated Coverage on the Stock With an Overweight Rating and Announced a $30 Price Target
摩根士丹利开始对COMPASS Pathways进行增持评级并宣布目标股价为30美元后,COMPASS Pathways股价走高
COMPASS Pathways Shares Are Trading Higher After Morgan Stanley Initiated Coverage on the Stock With an Overweight Rating and Announced a $30 Price Target
摩根士丹利开始对COMPASS Pathways进行增持评级并宣布目标股价为30美元后,COMPASS Pathways股价走高
使用浏览器的分享功能,分享给你的好友吧